- Home
- ZYXI vs ENGN Comparison
ZYXI vs ENGN Comparison
Compare ZYXI & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- ENGN
- Stock Information
- Founded
- ZYXI 1996
- ENGN 1999
- Country
- ZYXI United States
- ENGN Canada
- Employees
- ZYXI N/A
- ENGN N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ENGN
- Sector
- ZYXI Health Care
- ENGN
- Exchange
- ZYXI Nasdaq
- ENGN Nasdaq
- Market Cap
- ZYXI 265.0M
- ENGN 293.1M
- IPO Year
- ZYXI N/A
- ENGN N/A
- Fundamental
- Price
- ZYXI $8.58
- ENGN $5.83
- Analyst Decision
- ZYXI Strong Buy
- ENGN Strong Buy
- Analyst Count
- ZYXI 2
- ENGN 8
- Target Price
- ZYXI $14.00
- ENGN $30.38
- AVG Volume (30 Days)
- ZYXI 70.7K
- ENGN 200.8K
- Earning Date
- ZYXI 10-24-2024
- ENGN 12-19-2024
- Dividend Yield
- ZYXI N/A
- ENGN N/A
- EPS Growth
- ZYXI N/A
- ENGN N/A
- EPS
- ZYXI 0.15
- ENGN N/A
- Revenue
- ZYXI $193,665,000.00
- ENGN N/A
- Revenue This Year
- ZYXI $10.70
- ENGN N/A
- Revenue Next Year
- ZYXI $19.78
- ENGN N/A
- P/E Ratio
- ZYXI $55.86
- ENGN N/A
- Revenue Growth
- ZYXI 4.21
- ENGN N/A
- 52 Week Low
- ZYXI $7.15
- ENGN $4.42
- 52 Week High
- ZYXI $13.77
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- ZYXI 55.14
- ENGN 26.75
- Support Level
- ZYXI $8.13
- ENGN $5.68
- Resistance Level
- ZYXI $8.62
- ENGN $6.55
- Average True Range (ATR)
- ZYXI 0.29
- ENGN 0.69
- MACD
- ZYXI 0.04
- ENGN -0.24
- Stochastic Oscillator
- ZYXI 82.93
- ENGN 6.99
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.